Literature DB >> 32024920

Author Correction: Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals.

Ashok K Singh1, Archana S Bhadauria2, Umesh Kumar3, Vinit Raj1, Amit Rai1, Pranesh Kumar1, Amit K Keshari1, Dinesh Kumar3, Biswanath Maity3, Sneha Nath4, Anand Prakash4, Sudipta Saha5.   

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Entities:  

Year:  2020        PMID: 32024920      PMCID: PMC7002741          DOI: 10.1038/s41598-020-59134-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Correction to: Scientific Reports 10.1038/s41598-018-24288-0, published online 12 April 2018 This Article contains errors. The Legend for Figure 6 is incomplete, as it does not specify that the control data has been published in Figure 6 of a previous study[1]; these two studies were performed simultaneously, with the same normal control, positive control, and negative control groups. The Supplementary Information did not include full-length gel images. Uncropped images for Figure 4B are provided below as Figure 1.
Figure 1

.

.
  1 in total

1.  5H-benzo[h]thiazolo[2,3-b]quinazolines ameliorate NDEA-induced hepatocellular carcinogenesis in rats through IL-6 downregulation along with oxidative and metabolic stress reduction.

Authors:  Amit K Keshari; Ashok K Singh; Umesh Kumar; Vinit Raj; Amit Rai; Pranesh Kumar; Dinesh Kumar; Biswanath Maity; Sneha Nath; Anand Prakash; Sudipta Saha
Journal:  Drug Des Devel Ther       Date:  2017-10-13       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.